Clinical Trial Update: DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone [Phase 1]

View source ↗

Summary

Phase 1 trial comparing 2% Lovastatin/2% Cholesterol versus 2% Lovastatin alone for actinic porokeratosis; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Porokeratosis

Drugs mentioned

• Lovastatin 2% (Lovastatin)
• Lovastatin/Cholesterol 2% combination

Snippet

Sponsor: Medical University of South Carolina | Conditions: Actinic Porokeratosis | Phase 1 | Status: COMPLETED | Results posted: 2023-12-07